Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 03, 2017 Filed Nov 7, 2017 21:07 UTC |
Abdun-Nabi DanielDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $14.44 | $0.00 |
DisclosureSEC source: 0001140361-17-041378 · doc1.xml · derivative · entry 7 Abdun-Nabi Daniel · CIK 0001380187 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,906 Underlying: Common Stock · 20,000 shares Expires 2019-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. F6 · derivative.exercise_date: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 21:07 UTC |
Abdun-Nabi DanielDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 11,508 | $0.00 Strike: $22.03 | $0.00 |
DisclosureSEC source: 0001140361-17-041378 · doc1.xml · derivative · entry 6 Abdun-Nabi Daniel · CIK 0001380187 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,508 shares Expires 2018-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. F6 · derivative.exercise_date: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 21:07 UTC |
Abdun-Nabi DanielDirector · President & CEO
|
SaleCommon Stock | 20,000 | $42.92 | $858,400.00 |
DisclosureSEC source: 0001140361-17-041378 · doc1.xml · nonDerivative · entry 4 Abdun-Nabi Daniel · CIK 0001380187 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,134 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.70 to $43.00, inclusive. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 21:07 UTC |
Abdun-Nabi DanielDirector · President & CEO
|
Exercise / conversionCommon Stock | 20,000 | $14.44 | $288,800.00 |
DisclosureSEC source: 0001140361-17-041378 · doc1.xml · nonDerivative · entry 3 Abdun-Nabi Daniel · CIK 0001380187 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 21:07 UTC |
Abdun-Nabi DanielDirector · President & CEO
|
SaleCommon Stock | 11,508 | $42.50 | $489,090.00 |
DisclosureSEC source: 0001140361-17-041378 · doc1.xml · nonDerivative · entry 2 Abdun-Nabi Daniel · CIK 0001380187 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,134 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.47 to $42.78, inclusive. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 21:07 UTC |
Abdun-Nabi DanielDirector · President & CEO
|
Exercise / conversionCommon Stock | 11,508 | $22.03 | $253,521.24 |
DisclosureSEC source: 0001140361-17-041378 · doc1.xml · nonDerivative · entry 1 Abdun-Nabi Daniel · CIK 0001380187 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi. Read SEC document |
| September 29, 2017 Filed Sep 29, 2017 22:04 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 25,000 | $40.50 | $1,012,500.00 |
DisclosureSEC source: 0000899243-17-022995 · doc4.xml · nonDerivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,530,216 F1 · kind: All sales listed on this Form 4 were made by Mr. El-Hibri pursuant to a trading plan adopted on February 28, 2017 that is intended to comply with Rule 10b5-1(c) under the Exchange Act. Read SEC document |
| September 28, 2017 Filed Sep 29, 2017 23:04 UTC |
Richard RonaldDirector
|
Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 22,415 | $0.00 Strike: $7.99 | $0.00 |
DisclosureSEC source: 0001140361-17-037011 · doc1.xml · derivative · entry 6 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,415 shares Expires 2018-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. F4 · derivative.exercise_date: The option grant is fully vested. Read SEC document |
| September 28, 2017 Filed Sep 29, 2017 23:04 UTC |
Richard RonaldDirector
|
SaleCommon Stock | 22,415 | $40.00 | $896,600.00 |
DisclosureSEC source: 0001140361-17-037011 · doc1.xml · nonDerivative · entry 4 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,410 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.05, inclusive. Read SEC document |
| September 28, 2017 Filed Sep 29, 2017 23:04 UTC |
Richard RonaldDirector
|
Exercise / conversionCommon Stock | 22,415 | $7.99 | $179,095.85 |
DisclosureSEC source: 0001140361-17-037011 · doc1.xml · nonDerivative · entry 3 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,825 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard. Read SEC document |
| September 27, 2017 Filed Sep 29, 2017 23:04 UTC |
Richard RonaldDirector
|
Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 1,266 | $0.00 Strike: $7.99 | $0.00 |
DisclosureSEC source: 0001140361-17-037011 · doc1.xml · derivative · entry 5 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,415 Underlying: Common Stock · 1,266 shares Expires 2018-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. F4 · derivative.exercise_date: The option grant is fully vested. Read SEC document |
| September 27, 2017 Filed Sep 29, 2017 23:04 UTC |
Richard RonaldDirector
|
SaleCommon Stock | 1,266 | $40.00 | $50,640.00 |
DisclosureSEC source: 0001140361-17-037011 · doc1.xml · nonDerivative · entry 2 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,410 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard. Read SEC document |
| September 27, 2017 Filed Sep 29, 2017 23:04 UTC |
Richard RonaldDirector
|
Exercise / conversionCommon Stock | 1,266 | $7.99 | $10,115.34 |
DisclosureSEC source: 0001140361-17-037011 · doc1.xml · nonDerivative · entry 1 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard. Read SEC document |
| September 27, 2017 Filed Sep 29, 2017 22:04 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 25,000 | $39.50 | $987,500.00 |
DisclosureSEC source: 0000899243-17-022995 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,555,216 F1 · kind: All sales listed on this Form 4 were made by Mr. El-Hibri pursuant to a trading plan adopted on February 28, 2017 that is intended to comply with Rule 10b5-1(c) under the Exchange Act. Read SEC document |
| September 27, 2017 Filed Sep 29, 2017 20:52 UTC |
Havey AdamEVP, Business Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,885 | $0.00 Strike: $22.03 | $0.00 |
DisclosureSEC source: 0001140361-17-036981 · doc1.xml · derivative · entry 3 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,885 shares Expires 2018-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. F3 · derivative.exercise_date: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. Read SEC document |
| September 27, 2017 Filed Sep 29, 2017 20:52 UTC |
Havey AdamEVP, Business Operations
|
SaleCommon Stock | 7,885 | $39.50 | $311,457.50 |
DisclosureSEC source: 0001140361-17-036981 · doc1.xml · nonDerivative · entry 2 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,046 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey. Read SEC document |
| September 27, 2017 Filed Sep 29, 2017 20:52 UTC |
Havey AdamEVP, Business Operations
|
Exercise / conversionCommon Stock | 7,885 | $22.03 | $173,706.55 |
DisclosureSEC source: 0001140361-17-036981 · doc1.xml · nonDerivative · entry 1 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey. Read SEC document |
| September 27, 2017 Filed Sep 29, 2017 20:36 UTC |
Abdun-Nabi DanielDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $22.03 | $0.00 |
DisclosureSEC source: 0001140361-17-036963 · doc1.xml · derivative · entry 4 Abdun-Nabi Daniel · CIK 0001380187 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,508 Underlying: Common Stock · 15,000 shares Expires 2018-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. F5 · derivative.exercise_date: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. Read SEC document |
| September 27, 2017 Filed Sep 29, 2017 20:36 UTC |
Abdun-Nabi DanielDirector · President & CEO
|
SaleCommon Stock | 15,000 | $39.92 | $598,770.00 |
DisclosureSEC source: 0001140361-17-036963 · doc1.xml · nonDerivative · entry 2 Abdun-Nabi Daniel · CIK 0001380187 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,134 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.85 to $39.98, inclusive. Read SEC document |
| September 27, 2017 Filed Sep 29, 2017 20:36 UTC |
Abdun-Nabi DanielDirector · President & CEO
|
Exercise / conversionCommon Stock | 15,000 | $22.03 | $330,450.00 |
DisclosureSEC source: 0001140361-17-036963 · doc1.xml · nonDerivative · entry 1 Abdun-Nabi Daniel · CIK 0001380187 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi. Read SEC document |
| September 14, 2017 Filed Sep 14, 2017 21:27 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 23,547 | $38.50 | $906,559.50 |
DisclosureSEC source: 0000899243-17-022088 · doc4.xml · nonDerivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,580,216 F1 · kind: All sales listed on this Form 4 were made by Mr. El-Hibri pursuant to a trading plan adopted on February 28, 2017 that is intended to comply with Rule 10b5-1(c) under the Exchange Act. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 21:27 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 1,453 | $38.50 | $55,940.50 |
DisclosureSEC source: 0000899243-17-022088 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,603,763 F1 · kind: All sales listed on this Form 4 were made by Mr. El-Hibri pursuant to a trading plan adopted on February 28, 2017 that is intended to comply with Rule 10b5-1(c) under the Exchange Act. Read SEC document |
| September 08, 2017 Filed Sep 12, 2017 19:56 UTC |
Havey AdamEVP, Business Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,885 | $0.00 Strike: $22.03 | $0.00 |
DisclosureSEC source: 0001140361-17-035190 · doc1.xml · derivative · entry 3 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,885 Underlying: Common Stock · 7,885 shares Expires 2018-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. F4 · derivative.exercise_date: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. Read SEC document |
| September 08, 2017 Filed Sep 12, 2017 19:56 UTC |
Havey AdamEVP, Business Operations
|
SaleCommon Stock | 7,885 | $37.06 | $292,242.54 |
DisclosureSEC source: 0001140361-17-035190 · doc1.xml · nonDerivative · entry 2 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,046 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.87 to $37.59, inclusive. Read SEC document |
| September 08, 2017 Filed Sep 12, 2017 19:56 UTC |
Havey AdamEVP, Business Operations
|
Exercise / conversionCommon Stock | 7,885 | $22.03 | $173,706.55 |
DisclosureSEC source: 0001140361-17-035190 · doc1.xml · nonDerivative · entry 1 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey. Read SEC document |
| September 07, 2017 Filed Sep 8, 2017 18:31 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 16,439 | $37.50 | $616,462.50 |
DisclosureSEC source: 0000899243-17-021646 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,605,216 F1 · kind: All sales listed on this Form 4 were made by Mr. El-Hibri pursuant to a trading plan adopted on February 28, 2017 that is intended to comply with Rule 10b5-1(c) under the Exchange Act. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 22:21 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 3,100 | $37.50 | $116,250.00 |
DisclosureSEC source: 0000899243-17-021545 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,621,655 F1 · kind: All sales listed on this Form 4 were made by Mr. El-Hibri pursuant to a trading plan adopted on February 28, 2017 that is intended to comply with Rule 10b5-1(c) under the Exchange Act. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 23:31 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 5,461 | $37.50 | $204,787.50 |
DisclosureSEC source: 0000899243-17-021371 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,624,755 F1 · kind: All sales listed on this Form 4 were made by Mr. El-Hibri pursuant to a trading plan adopted on February 28, 2017 that is intended to comply with Rule 10b5-1(c) under the Exchange Act. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:16 UTC |
Abdun-Nabi DanielDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $22.03 | $0.00 |
DisclosureSEC source: 0001140361-17-034333 · doc1.xml · derivative · entry 3 Abdun-Nabi Daniel · CIK 0001380187 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,508 Underlying: Common Stock · 15,000 shares Expires 2018-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. F4 · derivative.exercise_date: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:16 UTC |
Abdun-Nabi DanielDirector · President & CEO
|
SaleCommon Stock | 15,000 | $37.21 | $558,150.00 |
DisclosureSEC source: 0001140361-17-034333 · doc1.xml · nonDerivative · entry 2 Abdun-Nabi Daniel · CIK 0001380187 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,134 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.14 to $37.27, inclusive. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:16 UTC |
Abdun-Nabi DanielDirector · President & CEO
|
Exercise / conversionCommon Stock | 15,000 | $22.03 | $330,450.00 |
DisclosureSEC source: 0001140361-17-034333 · doc1.xml · nonDerivative · entry 1 Abdun-Nabi Daniel · CIK 0001380187 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 16:32 UTC |
Hauer Jerome MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,153 | $0.00 Strike: $25.47 | $0.00 |
DisclosureSEC source: 0001140361-17-032607 · doc1.xml · derivative · entry 3 Hauer Jerome M · CIK 0001294935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,152 Underlying: Common Stock · 5,153 shares Expires 2022-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Consists of an option granted on January 22, 2015 under the company's stock incentive plan as amended and restated. F3 · derivative.exercise_date: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 16:32 UTC |
Hauer Jerome MDirector
|
SaleCommon Stock | 10,776 | $35.83 | $386,149.34 |
DisclosureSEC source: 0001140361-17-032607 · doc1.xml · nonDerivative · entry 2 Hauer Jerome M · CIK 0001294935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,645 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.70 to $36.05, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 16:32 UTC |
Hauer Jerome MDirector
|
GrantCommon Stock | 5,153 | $25.47 | $131,246.91 |
DisclosureSEC source: 0001140361-17-032607 · doc1.xml · nonDerivative · entry 1 Hauer Jerome M · CIK 0001294935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,421 F1 · security: Consists of an option granted on January 22, 2015 under the company's stock incentive plan as amended and restated. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 17:21 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
GrantEmployee stock option (right to buy) · Derivative | 20,083 | $0.00 Strike: $36.09 | $0.00 |
DisclosureSEC source: 0001140361-17-031028 · doc1.xml · derivative · entry 2 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,083 Underlying: Common Stock · 20,083 shares Expires 2024-08-07 F3 · derivative.exercise_date: Vests in three equal installments on August 7, 2018, August 7, 2019 and August 7, 2020. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 17:21 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
GrantCommon Stock | 12,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-031028 · doc1.xml · nonDerivative · entry 1 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,814 F1 · security: Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan. F2 · shares: These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| July 27, 2017 Filed Jul 28, 2017 18:12 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 25,000 | $36.50 | $912,500.00 |
DisclosureSEC source: 0000899243-17-019269 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,630,216 F1 · kind: All sales listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 28, 2017 that is intended to comply with Rule 10b5-1(c) under the Exchange Act. Read SEC document |
| July 20, 2017 Filed Jul 21, 2017 21:27 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 25,000 | $35.50 | $887,500.00 |
DisclosureSEC source: 0000899243-17-018715 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,655,216 F1 · kind: All sales listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 28, 2017 that is intended to comply with Rule 10b5-1(c) under the Exchange Act. Read SEC document |
| May 25, 2017 Filed May 26, 2017 18:13 UTC |
Zoon Kathryn CDirector
|
GrantCommon Stock | 8,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022484 · doc1.xml · nonDerivative · entry 1 Zoon Kathryn C · CIK 0001685720 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,485 F1 · security: Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan. F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date. Read SEC document |
| May 25, 2017 Filed May 26, 2017 13:46 UTC |
Bailey SueDirector
|
GrantCommon Stock | 8,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022469 · doc1.xml · nonDerivative · entry 1 Bailey Sue · CIK 0001403769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,077 F1 · security: Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan. F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date. Read SEC document |
| May 25, 2017 Filed May 26, 2017 14:16 UTC |
Hauer Jerome MDirector
|
GrantCommon Stock | 8,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022488 · doc1.xml · nonDerivative · entry 1 Hauer Jerome M · CIK 0001294935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,268 F1 · security: Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan. F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date Read SEC document |
| May 25, 2017 Filed May 26, 2017 13:22 UTC |
JOULWAN GEORGE ADirector
|
GrantCommon Stock | 8,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022459 · doc1.xml · nonDerivative · entry 4 JOULWAN GEORGE A · CIK 0001222197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,377 F4 · security: Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan. F5 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date. Read SEC document |
| May 25, 2017 Filed May 26, 2017 17:23 UTC |
SULLIVAN LOUIS WDirector
|
GrantCommon Stock | 8,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022461 · doc1.xml · nonDerivative · entry 4 SULLIVAN LOUIS W · CIK 0001193522 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,077 F4 · security: Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan. F5 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date. Read SEC document |
| May 25, 2017 Filed May 26, 2017 18:18 UTC |
Harsanyi ZsoltDirector
|
GrantCommon Stock | 8,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022490 · doc1.xml · nonDerivative · entry 4 Harsanyi Zsolt · CIK 0001380184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,077 F4 · security: Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan. F5 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date. Read SEC document |
| May 25, 2017 Filed May 26, 2017 17:44 UTC |
Richard RonaldDirector
|
GrantCommon Stock | 8,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022467 · doc1.xml · nonDerivative · entry 1 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,410 F1 · security: Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan. F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 20:14 UTC |
Havey AdamEVP, Biodefense Divison
|
SaleCommon Stock | 11,419 | $28.62 | $326,808.35 |
DisclosureSEC source: 0001140361-17-014647 · doc1.xml · nonDerivative · entry 1 Havey Adam · CIK 0001514588 · EVP, Biodefense Divison 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,046 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.50 to $29.19, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 15:28 UTC |
Havey AdamEVP, Biodefense Divison
|
GiftCommon Stock | 1,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-012231 · doc1.xml · nonDerivative · entry 1 Havey Adam · CIK 0001514588 · EVP, Biodefense Divison 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,465 F1 · kind: This transaction involved a gift of issuer common stock by the reporting person to a charitable gift fund. Read SEC document |
| March 10, 2017 Filed Mar 11, 2017 02:38 UTC |
Havey AdamEVP, Biodefense Divison
|
Tax withholdingCommon Stock | 1,624 | $31.05 | $50,425.20 |
DisclosureSEC source: 0001140361-17-011684 · doc1.xml · nonDerivative · entry 2 Havey Adam · CIK 0001514588 · EVP, Biodefense Divison 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,265 F1 · security: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended. Read SEC document |
| March 10, 2017 Filed Mar 11, 2017 02:30 UTC |
Kramer RobertEVP, Corproate Services Div
|
Tax withholdingCommon Stock | 3,007 | $31.05 | $93,367.35 |
DisclosureSEC source: 0001140361-17-011682 · doc1.xml · nonDerivative · entry 2 Kramer Robert · CIK 0001380956 · EVP, Corproate Services Div 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,095 F1 · security: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended. Read SEC document |
| March 10, 2017 Filed Mar 11, 2017 02:10 UTC |
Abdun-Nabi DanielDirector · President & CEO
|
Tax withholdingCommon Stock | 10,738 | $31.05 | $333,414.90 |
DisclosureSEC source: 0001140361-17-011680 · doc1.xml · nonDerivative · entry 2 Abdun-Nabi Daniel · CIK 0001380187 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,134 F1 · security: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.